Literature DB >> 2143347

Characterization of a Ca2(+)-ATPase in osteoclast plasma membrane.

P J Bekker1, C V Gay.   

Abstract

The plasma membrane fraction of chicken osteoclasts was purified utilizing 20% continuous Percoll gradients. Biochemical marker enzyme analysis (ouabain-sensitive Na+,K(+)-ATPase and 5'-nucleotidase) indicated that plasma membrane enrichment was 11.87-fold and 7.25-fold, respectively, and contamination with mitochondria, endoplasmic reticulum, and lysosomes was low as determined by succinic dehydrogenase, NADH dehydrogenase, and N-acetylglucosaminidase activities, respectively. SDS latency of Na+,K(+)-ATPase and 5'-nucleotidase activities of the isolated plasma membranes revealed that 43-50% of vesicles were sealed, with 10-16% in the inside-out orientation, depending on the membrane fraction used. Electron microscopy confirmed the vesicular nature of the plasma membrane fraction. The plasma membrane Ca2(+)-ATPase had a high-affinity (KCa = 0.22 microM; Vmax = 0.16 mumol/mg per min) and a low-affinity (KCa = 148 microM; Vmax = 0.37 mumol/mg per min) component. Calmodulin (0.12 microM) had no effect on Ca2(+)-ATPase activity. However, trifluoperazine (0.1 mM), a calmodulin antagonist, strongly inhibited especially the high-affinity component of the enzyme. Vanadate and lanthanum also caused inhibition. In the presence of CDTA, a potent Ca2+ and Mg2+ chelating agent, high-affinity Ca2(+)-ATPase activity was abolished, indicating that trace Mg2+ was essential for activity. The Ca2(+)-ATPase substrate curve using ATP showed a high-affinity (Km = 12.3 microM; Vmax = 0.022 mumol/mg per min) and a low-affinity (Km = 43.8 microM; Vmax = 0.278 mumol/mg per min) component. These results demonstrate that osteoclasts have a plasma membrane Ca2(+)-ATPase with characteristics similar to the enzyme responsible for active calcium extrusion in other cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143347     DOI: 10.1002/jbmr.5650050605

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  Demonstration of calmodulin-sensitive calcium translocation by isolated osteoclast plasma membrane vesicles.

Authors:  P J Bekker; C V Gay
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

Review 2.  Calcium and bone disease.

Authors:  Harry C Blair; Lisa J Robinson; Christopher L-H Huang; Li Sun; Peter A Friedman; Paul H Schlesinger; Mone Zaidi
Journal:  Biofactors       Date:  2011-06-14       Impact factor: 6.113

Review 3.  Mechanisms balancing skeletal matrix synthesis and degradation.

Authors:  Harry C Blair; Mone Zaidi; Paul H Schlesinger
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

4.  Localization of H(+)-ATPase and carbonic anhydrase II in ameloblasts at maturation.

Authors:  H M Lin; H Nakamura; T Noda; H Ozawa
Journal:  Calcif Tissue Int       Date:  1994-07       Impact factor: 4.333

Review 5.  Calcium signalling and calcium transport in bone disease.

Authors:  H C Blair; P H Schlesinger; C L H Huang; M Zaidi
Journal:  Subcell Biochem       Date:  2007

6.  Necessity of inositol (1,4,5)-trisphosphate receptor 1 and mu-calpain in NO-induced osteoclast motility.

Authors:  Beatrice B Yaroslavskiy; Allison C Sharrow; Alan Wells; Lisa J Robinson; Harry C Blair
Journal:  J Cell Sci       Date:  2007-08-15       Impact factor: 5.285

Review 7.  Role of regulator of G protein signaling proteins in bone.

Authors:  David Keinan; Shuying Yang; Robert E Cohen; Xue Yuan; Tongjun Liu; Yi-Ping Li
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

Review 8.  Osteoclastic differentiation and function regulated by old and new pathways.

Authors:  Harry C Blair; Mone Zaidi
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.